Controversies

CR Sanjiu subsidiary recalls Shuxuening Injection, halts production and sales after sampling failure

Securities Times reported that a sampling inspection on February 17, 2015 found two batches of Shuxuening Injection from China Resources Gaoke to be nonconforming. The company recalled the relevant batches and voluntarily expanded the recall, suspended production and sales of the product, and carried out risk assessment and rectification. The company said at the time that it had not received reports of serious adverse reactions. Progress: the company announcement confirmed the recall and suspension of production and sales. Entities involved: Beijing China Resources Gaoke Natural Medicine Co., Ltd.; China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Scope: under the original list, this is linked to the China Resources Sanjiu traditional Chinese medicine business name; the manufacturing company involved is Beijing China Resources Gaoke, not that business name being independently penalized.